These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 4792579)

  • 1. [Hepatic transport of bilirubin in normal and cirrhotic patients. Compartmental analysis of plasma bilirubin disappearance curves following intravenous overloading].
    Pirotte J
    Biol Gastroenterol (Paris); 1973; 6(3):183-96. PubMed ID: 4792579
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of corticosteroid treatment on bilirubin metabolism in chronic aggressive hepatitis.
    Kawasaki H; Ogata T; Irisa T; Hirayama C
    Acta Hepatogastroenterol (Stuttg); 1977 Jun; 24(3):175-81. PubMed ID: 883466
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Bilirubin metabolism in liver cirrhosis].
    Ohkubo A
    Nihon Rinsho; 1994 Jan; 52(1):138-44. PubMed ID: 8114283
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Hepatic clearance of 99mTc-p-butyl HIDA in liver diseases. Correlations with routine hematochemical parameters of liver function].
    Custro N; De Francisci MC; Patanella I; Scafidi V; Indovina I
    Minerva Med; 1984 Nov; 75(42):2527-32. PubMed ID: 6083507
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effects of acute infectious hepatitis and cirrhosis of the liver on the nonerythropoietic component of early bilirubin.
    Tarao K; Fukushima K; Endo O; Kamiyo A
    J Lab Clin Med; 1976 Feb; 87(2):240-50. PubMed ID: 1245790
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Half-life time or clearance of indocyanine green in patients with liver disease.
    Gilmore IT; Marigold JH; Thompson RP
    Hepatogastroenterology; 1982 Apr; 29(2):55-7. PubMed ID: 7084884
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of indocyanine green clearance with Child's-Pugh score and hepatic histology: a multivariate analysis.
    Mukherjee S; Rogers MA; Buniak B
    Hepatogastroenterology; 2006; 53(67):120-3. PubMed ID: 16506389
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Proceedings: A simple method for the calculation of hepatic bilirubin clearance: its use in patients with Gilbert's syndrome].
    Kutz K; Egger G; Bachofen H; Preisig R
    Helv Med Acta; 1974 May; 37(5-6):386-7. PubMed ID: 4410538
    [No Abstract]   [Full Text] [Related]  

  • 9. Hepatic organic anion transport following portacaval shunt in patients with cirrhosis.
    Zsigmond GL; Bodnár A; Karácsonyi S
    Acta Chir Hung; 1984; 25(2):97-106. PubMed ID: 6464621
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Mathematical model of bilirubin transport].
    Zhulanov SV; Tokin IB; Filimonova GF
    Biofizika; 1997; 42(5):1094-6. PubMed ID: 9410036
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Studies of pigment metabolism in patients with chronic viral hepatitis and liver cirrhosis].
    Bochkova LM; Voronova GV
    Ter Arkh; 1976; 48(12):35-9. PubMed ID: 1013892
    [No Abstract]   [Full Text] [Related]  

  • 12. Unresponsiveness of hepatic nitrogen metabolism to glucagon infusion in patients with cirrhosis: dependence on liver cell failure.
    Fabbri A; Marchesini G; Bianchi G; Bugianesi E; Bortoluzzi L; Zoli M; Pisi E
    Hepatology; 1993 Jul; 18(1):28-35. PubMed ID: 8325618
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alteration of the plasma disappearance and biliary excretion patterns of exogenously administered bilirubin by alpha-nephthylisothiocyanate.
    Roberts RJ; Plaa GL
    J Pharmacol Exp Ther; 1967 Feb; 115(2):330-6. PubMed ID: 6026532
    [No Abstract]   [Full Text] [Related]  

  • 14. Effects of glucose on hepatic conversion of aminonitrogen to urea in patients with cirrhosis: relationship to glucagon.
    Hamberg O; Vilstrup H
    Hepatology; 1994 Jan; 19(1):45-54. PubMed ID: 7903954
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics of melatonin in man: first pass hepatic metabolism.
    Lane EA; Moss HB
    J Clin Endocrinol Metab; 1985 Dec; 61(6):1214-6. PubMed ID: 4055987
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatic and intestinal cytochrome P450 3A activity in cirrhosis: effects of transjugular intrahepatic portosystemic shunts.
    Chalasani N; Gorski JC; Patel NH; Hall SD; Galinsky RE
    Hepatology; 2001 Dec; 34(6):1103-8. PubMed ID: 11731998
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Caffeine elimination in cirrhotic and non-cirrhotic liver disease of different etiology.
    Joeres R; Brachtel D; Gallenkamp H; Hofstetter G; Klinker H; Zilly W; Richter E
    Z Gastroenterol; 1993 Feb; 31 Suppl 2():56-61. PubMed ID: 7483716
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Studies on the kinetics of unconjugated [14C]bilirubin metabolism in normal subjects and patients with compensated cirrhosis.
    Owens D; Jones EA; Carson ER
    Clin Sci Mol Med; 1977 Jun; 52(6):555-70. PubMed ID: 884928
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 51Cr red cell survival studies in normal subjects and in patients affected by hemolytic disorders. An approach to the calculation of hepatic bilirubin clearance by radiochromium.
    Fresco G; Fontana B; Biggi A
    J Nucl Med Allied Sci; 1977; 21(3):93-7. PubMed ID: 599385
    [No Abstract]   [Full Text] [Related]  

  • 20. Use of kinetic analysis and mathematical modeling in the study of metabolic pathways in vivo. Applications to hepatic organic anion metabolism. (First of two parts).
    Carson ER; Jones EA
    N Engl J Med; 1979 May; 300(18):1016-27. PubMed ID: 372804
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.